MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $272,000 | -21.4% | 18,997 | +49.6% | 0.07% | +70.0% |
Q4 2019 | $346,000 | +27.2% | 12,700 | +33.7% | 0.04% | +8.1% |
Q3 2019 | $272,000 | -86.8% | 9,500 | -84.7% | 0.04% | -82.3% |
Q1 2019 | $2,066,000 | +38.8% | 62,224 | +21.5% | 0.21% | +21.5% |
Q4 2018 | $1,489,000 | +36.6% | 51,225 | +116.1% | 0.17% | +186.7% |
Q3 2018 | $1,090,000 | -52.0% | 23,700 | -61.0% | 0.06% | -46.9% |
Q2 2018 | $2,272,000 | -4.9% | 60,800 | -24.8% | 0.11% | -10.3% |
Q1 2018 | $2,388,000 | -29.8% | 80,800 | -18.4% | 0.13% | -39.1% |
Q4 2017 | $3,402,000 | +28.8% | 99,058 | +35.7% | 0.21% | +15.0% |
Q3 2017 | $2,641,000 | +41.2% | 73,000 | +0.8% | 0.18% | +47.5% |
Q2 2017 | $1,871,000 | -20.2% | 72,400 | -40.7% | 0.12% | -3.2% |
Q1 2017 | $2,344,000 | -6.7% | 122,058 | -19.0% | 0.13% | -16.0% |
Q4 2016 | $2,513,000 | -19.7% | 150,737 | -0.9% | 0.15% | -10.7% |
Q3 2016 | $3,129,000 | -29.5% | 152,039 | +4.8% | 0.17% | -31.4% |
Q2 2016 | $4,439,000 | -8.3% | 145,063 | +12.2% | 0.24% | -20.7% |
Q1 2016 | $4,841,000 | -10.9% | 129,328 | +2.7% | 0.31% | +16.2% |
Q4 2015 | $5,435,000 | +89.4% | 125,932 | +64.5% | 0.27% | +88.7% |
Q3 2015 | $2,869,000 | +75.4% | 76,537 | +59.0% | 0.14% | +123.8% |
Q2 2015 | $1,636,000 | -23.2% | 48,137 | -20.0% | 0.06% | -25.9% |
Q1 2015 | $2,129,000 | -14.5% | 60,137 | -17.8% | 0.08% | -51.1% |
Q4 2014 | $2,491,000 | +49.1% | 73,148 | +68.8% | 0.17% | +97.7% |
Q3 2014 | $1,671,000 | +309.6% | 43,331 | +313.3% | 0.09% | +388.9% |
Q2 2014 | $408,000 | -3.1% | 10,485 | -14.9% | 0.02% | -40.0% |
Q1 2014 | $421,000 | -33.1% | 12,328 | -58.9% | 0.03% | -40.0% |
Q4 2013 | $629,000 | -70.0% | 29,963 | -66.4% | 0.05% | -69.9% |
Q3 2013 | $2,095,000 | +280.2% | 89,156 | +334.7% | 0.17% | +155.4% |
Q2 2013 | $551,000 | – | 20,508 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |